BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chandrasekaran B, Samarneh S, Jaber AMY, Kassab G, Agrawal N. Therapeutic Potentials of A2B Adenosine Receptor Ligands: Current Status and Perspectives. Curr Pharm Des 2019;25:2741-71. [PMID: 31333084 DOI: 10.2174/1381612825666190717105834] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Li Z, Kou L, Fu X, Xie Z, Xu M, Guo L, Lin T, Gong S, Zhang S, Liu M. Design, synthesis, and biological evaluation of triazole-pyrimidine-methylbenzonitrile derivatives as dual A2A/A2B adenosine receptor antagonists. J Enzyme Inhib Med Chem 2022;37:1514-26. [PMID: 35616298 DOI: 10.1080/14756366.2022.2077731] [Reference Citation Analysis]
2 Voss JH, Mahardhika AB, Inoue A, Müller CE. Agonist-Dependent Coupling of the Promiscuous Adenosine A2B Receptor to Gα Protein Subunits. ACS Pharmacol Transl Sci 2022;5:373-86. [PMID: 35592437 DOI: 10.1021/acsptsci.2c00020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Wang J, Bhattarai A, Do HN, Akhter S, Miao Y. Molecular Simulations and Drug Discovery of Adenosine Receptors. Molecules 2022;27:2054. [PMID: 35408454 DOI: 10.3390/molecules27072054] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Saini A, Patel R, Gaba S, Singh G, Gupta GD, Monga V. Adenosine receptor antagonists: Recent advances and therapeutic perspective. Eur J Med Chem 2021;227:113907. [PMID: 34695776 DOI: 10.1016/j.ejmech.2021.113907] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
5 da Silva ACR, Araujo JSC, Pita SSDR, Leite FHA. In silico development of adenosine A2B receptor antagonists for sickle cell disease. J Biomol Struct Dyn 2021;:1-10. [PMID: 34180379 DOI: 10.1080/07391102.2021.1934121] [Reference Citation Analysis]
6 Coppi E, Cencetti F, Cherchi F, Venturini M, Donati C, Bruni P, Pedata F, Pugliese AM. A2 B Adenosine Receptors and Sphingosine 1-Phosphate Signaling Cross-Talk in Oligodendrogliogenesis. Front Neurosci 2021;15:677988. [PMID: 34135730 DOI: 10.3389/fnins.2021.677988] [Reference Citation Analysis]
7 Lindemann M, Dukic-Stefanovic S, Hinz S, Deuther-Conrad W, Teodoro R, Juhl C, Steinbach J, Brust P, Müller CE, Wenzel B. Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A2B Receptor Binding Affinity. Pharmaceuticals (Basel) 2021;14:485. [PMID: 34069548 DOI: 10.3390/ph14050485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Barresi E, Martini C, Da Settimo F, Greco G, Taliani S, Giacomelli C, Trincavelli ML. Allosterism vs. Orthosterism: Recent Findings and Future Perspectives on A2B AR Physio-Pathological Implications. Front Pharmacol 2021;12:652121. [PMID: 33841166 DOI: 10.3389/fphar.2021.652121] [Reference Citation Analysis]
9 Coppi E, Dettori I, Cherchi F, Bulli I, Venturini M, Lana D, Giovannini MG, Pedata F, Pugliese AM. A2B Adenosine Receptors: When Outsiders May Become an Attractive Target to Treat Brain Ischemia or Demyelination. Int J Mol Sci 2020;21:E9697. [PMID: 33353217 DOI: 10.3390/ijms21249697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
10 Trapero C, Martín-Satué M. Purinergic Signaling in Endometriosis-Associated Pain. Int J Mol Sci 2020;21:E8512. [PMID: 33198179 DOI: 10.3390/ijms21228512] [Reference Citation Analysis]
11 Taliani S, Da Settimo F, Martini C, Laneri S, Novellino E, Greco G. Exploiting the Indole Scaffold to Design Compounds Binding to Different Pharmacological Targets. Molecules 2020;25:E2331. [PMID: 32429433 DOI: 10.3390/molecules25102331] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Deb PK. Therapeutic Potentials of Adenosine Receptors: The State of The Art. Curr Pharm Des 2019;25:2789-91. [PMID: 31674891 DOI: 10.2174/138161282526191007143942] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Deb PK. Progress in the Development of Agonists, Antagonists and Allosteric Modulators of Adenosine Receptors. CPD 2019;25:2695-6. [DOI: 10.2174/138161282525190916100149] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]